Risk Factors for Left Ventricular Dysfunction Following Surgical Management of Cardiac Fibroma

Rebecca S Beroukhim1,2, Tal Geva1,2, Pedro Del Nido3,2

  • 1Department of Cardiology (R.S.B., T.G., L.A.S., M.L., A.M., D.M.H., E.P.W.), Boston Children's Hospital.

Insights

Surgical removal of cardiac fibromas in children can lead to left ventricular (LV) dysfunction. Significant mitral regurgitation before surgery is the main predictor of this postoperative LV dysfunction.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Cardiac Imaging

Background:

  • Cardiac fibromas in children often require surgical resection to alleviate hemodynamic compromise and arrhythmias.
  • Postoperative left ventricular (LV) function following fibroma resection is not well understood.
  • This study investigates factors influencing LV dysfunction after surgical fibroma removal.

Purpose of the Study:

  • To evaluate factors associated with left ventricular (LV) dysfunction after surgical resection of cardiac fibromas in pediatric patients.
  • To identify predictors of impaired LV function post-surgery.

Main Methods:

  • Retrospective observational cohort study of 41 pediatric patients undergoing cardiac fibroma resection.
  • Analysis of preoperative and postoperative cardiovascular magnetic resonance (CMR) imaging data.
  • Assessment of tumor volume index, regional wall motion abnormality score, LV ejection fraction, and global circumferential strain.

Main Results:

  • Larger tumor volume index correlated with higher postoperative regional wall motion abnormality scores.
  • Postoperative CMR revealed increased LV end-diastolic volume, decreased LV ejection fraction, and reduced global circumferential strain.
  • Significant preoperative mitral regurgitation was the sole independent predictor of predischarge LV dysfunction (OR 22).

Conclusions:

  • Surgical resection of left ventricular (LV) fibromas is associated with regional wall motion abnormalities and reduced systolic function.
  • Children with significant preoperative mitral regurgitation face the highest risk of postoperative LV dysfunction.
  • Close surveillance is recommended for pediatric patients with cardiac fibromas and preoperative mitral regurgitation.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
126
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
173
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
110
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
224
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
148
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
262